Valitor has been accepted into the Spring 2016 cohort at SkyDeck. SkyDeck is a joint venture of UC Berkeley’s College of Engineering, the Haas School of Business, and the Vice Chancellor for Research Office. This unique ecosystem, is designed to give startup companies the opportunity to launch and compete with industry leaders.
Valitor is proud to announce the final close of our Series A financing, co-lead by the Berkeley Catalyst Fund and ShangPharma Innovations. This round oversubscribed our initial offering, and we raised
Valitor has been awarded a Phase I SBIR grant from the National Cancer Institute. This project will support validation of our platform technology to generate long-acting immunotherapies that can provi
Valitor has been awarded a Phase I SBIR grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. This project will continue the development of a long-acting anti-inflammat